Search

Author/Creator Qin, Albert

1. A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. Issue 11 (10th October 2022)

Authors:
Chen, Chi‐Yi; Chuang, Wan‐Long; Qin, Albert; Zhang, Wen‐Hua; Zhu, Li‐Ying; Zhang, Guo‐Qiang; Chen, Jyh‐Jou; Lo, Ching‐Chu; Zhou, Xinmin; Mao, Xiaorong; Shang, Jia; Kuo, Hsing‐Tao; Xie, Wen; Chen, Chien‐Hung; Lo, Gin‐Ho; Jun, Dae W; Dang, Shuangsuo; Tsai, Chan‐Yen; Wang, Ting‐Fang; Lai, Hsin‐Hui
Journal:
JGH open
Issue:
Volume 6:Issue 11(2022)
Page Start:
782
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial. Issue 5 (28th December 2021)

Authors:
Huang, Yi‐Wen; Qin, Albert; Fang, Jane; Wang, Ting‐Fang; Tsai, Chung‐Wei; Lin, Ko‐Chung; Teng, Ching‐Leou; Larouche, Richard
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 5(2022)
Page Start:
2396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy. Issue 8 (10th July 2021)

Authors:
Lin, Hsien‐Hong; Hsu, Shih‐Jer; Lu, Sheng‐Nan; Chuang, Wan‐Long; Hsu, Chao‐Wei; Chien, Rong‐Nan; Yang, Sien‐Sing; Su, Wei‐Wen; Wu, Jaw‐Ching; Lee, Tzong‐Hsi; Peng, Cheng‐Yuan; Tseng, Kuan‐Chiao; Qin, Albert; Huang, Yi‐Wen; Chen, Pei‐Jer
Journal:
JGH open
Issue:
Volume 5:Issue 8(2021)
Page Start:
929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗